Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Relapse (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00084916
What this trial is testing

CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+12 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)UnknownNCT05061147
What this trial is testing

Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Who this might be right for
LeukemiaAcute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid Leukemia+1 more
Maxinovel Pty., Ltd. 100
Testing effectiveness (Phase 2)UnknownNCT04884984
What this trial is testing

Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Study completedNCT00006040
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT04402723
What this trial is testing

Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 8
Testing effectiveness (Phase 2)Study completedNCT00782379
What this trial is testing

Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Northside Hospital, Inc. 20
Not applicableLooking for participantsNCT05124288
What this trial is testing

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

Who this might be right for
Acute Myeloid Leukemia, in Relapse
Ciceri Fabio 500
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT03556982
What this trial is testing

CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）

Who this might be right for
Leukemia, Myeloid, Acute
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Early research (Phase 1)Looking for participantsNCT05317403
What this trial is testing

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Medical College of Wisconsin 40
Testing effectiveness (Phase 2)Looking for participantsNCT06928662
What this trial is testing

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Who this might be right for
Acute Myeloid LeukemiaAcute Undifferentiated LeukemiaMixed Phenotype Acute Leukemia+11 more
Fred Hutchinson Cancer Center 36
Very early researchStudy completedNCT00424242
What this trial is testing

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Northwestern University 15
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02743611
What this trial is testing

Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeUveal Melanoma
Bellicum Pharmaceuticals 4
Testing effectiveness (Phase 2)Ended earlyNCT05984199
What this trial is testing

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Leukemia, Myeloid, Acute
Vor Biopharma 38
Early research (Phase 1)Active Not RecruitingNCT02890329
What this trial is testing

Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Previously Treated Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia, Myelodysplasia-Related+5 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Looking for participantsNCT06816134
What this trial is testing

Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaTransplantation, Stem Cell+1 more
The First Affiliated Hospital of Soochow University 48
Early research (Phase 1)Study completedNCT02017613
What this trial is testing

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies

Who this might be right for
Lymphoma, B-CellT-Cell Lymphoma
Rhizen Pharmaceuticals SA 35
Testing effectiveness (Phase 2)Ended earlyNCT02030405
What this trial is testing

Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Steven E. Coutre 4
Early research (Phase 1)Study completedNCT01690624
What this trial is testing

BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse

Who this might be right for
Leukemia, Myeloid, Acute
Boehringer Ingelheim 30
Next Page